SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
  
 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Bozeman Robert
(Last) (First) (Middle)
600 E. LAS COLINAS BLVD.
SUITE 1500
(Street)
IRVING TX 75039
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
DAEGIS INC. [ DAEG ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
04/14/2014
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 04/11/2014 P 5,000 A $1.36 10,000 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option $6.25 (1) 01/14/2018 Common Stock 4,000 4,000 D
Stock Option $6.4 (2) 05/02/2018 Common Stock 5,000 5,000 D
Stock Option $2.6 (3) 05/05/2019 Common Stock 6,500 6,500 D
Stock Option $3.56 (4) 05/04/2020 Common Stock 10,000 10,000 D
Stock Option $2.9 (5) 05/02/2021 Common Stock 5,000 5,000 D
Stock Option $1.92 (6) 07/01/2021 Common Stock 7,500 7,500 D
Stock Option $1.4 (7) 05/01/2022 Common Stock 12,500 12,500 D
Explanation of Responses:
1. Option granted 01/14/2008 pursuant to the 2001 Stock Option Plan and vests monthly as to one twelfth (1/12th) of the subject shares upon completion of each full month of continuous directorship with Daegis Inc. Option is exercisable to the extent vested.
2. Option granted 05/02/08 pursuant to the 2001 Stock Option Plan and vests monthly as to one twelfth (1/12th) of the subject shares upon completion of each full month of continuous directorship with Daegis Inc. Option is exercisable to the extent vested.
3. Option granted 05/05/09 pursuant to the 2001 Stock Option Plan and vests monthly as to one twelfth (1/12th) of the subject shares upon completion of each full month of continuous directorship with Daegis Inc. Option is exercisable to the extent vested.
4. Option granted 05/04/10 pursuant to the 2001 Stock Option Plan and vests monthly as to one twelfth (1/12th) of the subject shares upon completion of each full month of continuous directorship with Daegis Inc. Option is exercisable to the extent vested.
5. Option granted 05/02/11 pursuant to the 2010 Stock Option Plan and vests monthly as to one twelfth (1/12th) of the subject shares upon completion of each full month of continuous directorship with Daegis Inc. Option is exercisable to the extent vested.
6. Option granted 07/01/11 pursuant to the 2010 Stock Option Plan and vests monthly as to one tenth (1/10th) of the subject shares upon completion of each full month of continuous directorship with Daegis Inc. Option is exercisable to the extent vested.
7. Option granted 05/01/12 pursuant to the 2010 Stock Option Plan and vests monthly as to one twelfth (1/12th) of the subject shares upon completion of each full month of continuous directorship with Daegis Inc. Option is exercisable to the extent vested.
Remarks:
F1,F2, etc., no parenthesis. Footnotes cannot exceed 1,000 characters including spaces. You can use two footnotes if your footnote text exceed 1,000 characters. Add more rows as needed. Footnotes can only be associated with data in tables. To get a character count copy your footnote text into a new document and select Properties under the File menu. Click the Statistics tab and look at Characters (with spaces).
/s/ Amanda White, by power of attorney 04/14/2014
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.